Early research (Phase 1)Study completedNCT03780517
What this trial is testing
Safety, Efficacy, and Tolerability of BOS172738 in Patients With Advanced Rearranged During Transfection (RET) Gene-Altered Tumors
Who this might be right for
Advanced Nonhaematologic Malignancies
Boston Pharmaceuticals 117